ProBiotix Health Plc (AQU: PBX)

Market Cap	9.09M
Revenue (ttm)	2.13M
Net Income (ttm)	-496.00K
Shares Out	158.17M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	5.75
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About ProBiotix Health

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. It offers YourBiotix CH and InstaMelt, capsule formula which contains LPLDL for maintenance of healthy cholesterol; YourBiotix BP, a blood pressure-reducing tablet formula for hypertension and cardiovascular health; and YourBiotix VH, a vascular health capsule formula, indicated to work against the build-up of lipid and calcium deposits in the blood vessels. The company was forme...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2021
• Employees: 7
• Stock Exchange: Aquis Exchange
• Ticker Symbol: PBX

Financial Performance

In 2023, ProBiotix Health's revenue was 1.67 million, an increase of 49.19% compared to the previous year's 1.12 million. Losses were -747,000, 222.4% more than in 2022.